SEC EDGAR · Insider purchase
BOLT: Coastlands Capital LP reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
Follow BOLT- Became public
- Nov 10, 2026, 2:57 PM EST
- Event / period date
- Nov 9, 2026
- Collected
- Nov 10, 2026, 3:06 PM EST
Why this is connected
This filing identifies Bolt Biotherapeutics, Inc. as the issuer of the security. The company's SEC identifier connects it to BOLT.
Reported transactions
Coastlands Capital LP (10% owner)
50,000 shares · Common Stock
Nov 9, 2026 · $6.38 per share
Value calculated from the reported shares and prices: $319,000.00.
Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4</documentType>
<periodOfReport>2026-11-09</periodOfReport>
<notSubjectToSection16>0</notSubjectToSection16>
<issuer>
<issuerCik>0001641281</issuerCik>
<issuerName>Bolt Biotherapeutics, Inc.</issuerName>
<issuerTradingSymbol>BOLT</issuerTradingSymbol>
<issuerForeignTradingSymbol></issuerForeignTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0002068530</rptOwnerCik>
<rptOwnerName>Coastlands Capital LP</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>601 CALIFORNIA STREET</rptOwnerStreet1>
<rptOwnerStreet2>SUITE 1210</rptOwnerStreet2>
<rptOwnerCity>SAN FRANCISCO</rptOwnerCity>
<rptOwnerState>CA</rptOwnerState>
<rptOwnerZipCode>94108</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>0</isDirector>
<isOfficer>0</isOfficer>
<isTenPercentOwner>1</isTenPercentOwner>
<isOther>0</isOther>
<officerTitle></officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>0</aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value>Common Stock</value>
</securityTitle>
<transactionDate>
<value>2026-11-09</value>
</transactionDate>
<deemedExecutionDate></deemedExecutionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>0</equitySwapInvolved>
</transactionCoding>
<transactionTimeliness></transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value>50000</value>
</transactionShares>
<transactionPricePerShare>
<value>6.38</value>
<footnoteId id="F1"/>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>462416</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>I</value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value>By Coastlands Capital LP</value>
<footnoteId id="F2"/>
</natureOfOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<footnotes>
<footnote id="F1">The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $6.3618 to $6.4044. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the reporting persons will provide full information regarding the number of shares purchased at each separate price.</footnote>
<footnote id="F2">Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.</footnote>
</footnotes>
<ownerSignature>
<signatureName>/s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP</signatureName>
<signatureDate>2026-11-10</signatureDate>
</ownerSignature>
<ownerSignature>
<signatureName>/s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital Partners LP</signatureName>
<signatureDate>2026-11-10</signatureDate>
</ownerSignature>
<ownerSignature>
<signatureName>/s/ Mark Shamia, Chief Operating Officer of Coastlands Capital GP LLC</signatureName>
<signatureDate>2026-11-10</signatureDate>
</ownerSignature>
<ownerSignature>
<signatureName>/s/ Mark Shamia, Chief Operating Officer of Coastlands Capital LLC</signatureName>
<signatureDate>2026-11-10</signatureDate>
</ownerSignature>
<ownerSignature>
<signatureName>/s/ Matthew D. Perry</signatureName>
<signatureDate>2026-11-10</signatureDate>
</ownerSignature>
</ownershipDocument>Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.